LIMIT is an immunogenic lncRNA in cancer immunity and immunotherapy
LIMIT is an immunogenic lncRNA in cancer immunity and immunotherapy
About this item
Full title
Author / Creator
Li, Gaopeng , Kryczek, Ilona , Nam, Jutaek , Li, Xiong , Li, Shasha , Li, Jing , Wei, Shuang , Grove, Sara , Vatan, Linda , Zhou, Jiajia , Du, Wan , Lin, Heng , Wang, Ton , Subramanian, Chitra , Moon, James J. , Cieslik, Marcin , Cohen, Mark and Zou, Weiping
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
Major histocompatibility complex-I (MHC-I) presents tumour antigens to CD8
+
T cells and triggers anti-tumour immunity. Humans may have 30,000–60,000 long noncoding RNAs (lncRNAs). However, it remains poorly understood whether lncRNAs affect tumour immunity. Here, we identify a lncRNA, lncRNA inducing MHC-I and immunogenicity of tumour (LIMIT...
Alternative Titles
Full title
LIMIT is an immunogenic lncRNA in cancer immunity and immunotherapy
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8122078
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8122078
Other Identifiers
ISSN
1465-7392
E-ISSN
1476-4679
DOI
10.1038/s41556-021-00672-3
